Companies: 10,795·Total market cap: $144.5T
GSK plc

GSK plc

GSKNYSEHealthcare● Active
$51.52
+$0.25(+0.49%)
Market Cap$103.6B
P/E Ratio
52W High$61.7
52W Low$35.45

GSK plc (GSK) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

gsk · stock forecast · 29 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 29 Wall Street analysts in the past 3 months

SellBuy

Hold

29 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
9
Hold
16
Sell
4
Strong Sell
0
Total: 29 · Buy rate: 31.0%

12-Month Price Target

High

$85.00

Consensus

$52.45

+1.8% upside

Low

$35.25

Median: $53 · Last Close: $51.52

The GSK plc (GSK) analyst consensus is Hold, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month GSK price target is $52.45, representing +1.8% upside from the current price of $51.52.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $52 (1.8%)

Consensus Target

$52.45

1.8% upside

High Target

$85

65.0%

Low Target

$35.25

-31.6%

Current Price

$51.52

as of today

Based on analyst price targets, the GSK stock price prediction for the next 12 months ranges from $35.25 to $85. The consensus GSK price forecast of $52.45 implies 1.8% upside from the current price of $51.52.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$51.090.84%

1-day model range: $50.93–$51.24. Peak: $51.24 (-0.84%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$65+25.7%
2028$76+46.8%
2029$84+62.7%
2030$90+74.2%
2031+82.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

57%7%36%
8Buy
1Neutral
5Sell
RSI (14)61.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · GSK · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$50.16BUY
MA 10$50.71BUY
MA 20$50.67BUY
MA 50$53.33SELL
MA 100$54.04SELL
MA 200$49.54BUY
Current $GSK · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$50.74BUY
EMA 10$50.67BUY
EMA 20$51.04BUY
EMA 50$52.33SELL
EMA 100$52.26SELL
EMA 200$49.80BUY
Current $GSK · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Barclays2026-01-06
Downgrade ↓
Equal WeightUnderweight
Jefferies2024-11-12
Downgrade ↓
BuyHold
Guggenheim2024-10-31
Downgrade ↓
BuyNeutral
UBS2024-07-08
Downgrade ↓
BuyNeutral
Jefferies2024-07-02
Maintains
BuyBuy
Guggenheim2024-03-04
Upgrade ↑
NeutralBuy
Jefferies2024-01-03
Upgrade ↑
HoldBuy
DZ Bank2022-02-11
Downgrade ↓
BuyHold
Barclays2021-11-05
Upgrade ↑
UnderweightEqual Weight
SVB Leerink2021-03-23
Downgrade ↓
OutperformMarket Perform

Wall Street analysts have recently issued updated ratings on GSK plc (GSK) stock. Of the recent 61 rating actions, 24 were upgrades and 25 were downgrades. 29 analysts currently cover GSK.

Analyst Recommendation Trends

Buy ratings101
Hold ratings00
Sell ratings01↑ +1

GSK analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$45.6B

↓ 7.5% YoY

Revenue Next Year

$47.9B

↑ 5.0% YoY

EPS This Year

$4.83

EPS Next Year

$5.32

↑ 10.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast GSK EPS of $4.83 for the current fiscal year, based on estimates from 5 analysts. The GSK revenue forecast is $45.6B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The GSK stock forecast is supported by two independent data sources: analyst consensus ratings from 29 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GSK price target is $52.45 (+1.8% upside), with an analyst consensus of Hold.

The GSK short-term stock prediction for tomorrow is $51.09 (-0.84%). The GSK stock price prediction for 2027 estimates an average of $65. The GSK stock prediction for 2030 projects a range of $87–$93.

GSK plc trades on NYSE under the ticker GSK. The GSK stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 31% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

GSK forecast · 8 questions

According to 29 Wall Street analysts, the average 12-month GSK price target is $52.45, with a high forecast of $85.00 and a low of $35.25. The median price target is shown in the chart above when available. This implies +1.8% potential upside from the current price of $51.52.

GSK price targetWhat is GSK price targetGSK analyst price targetGSK 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.